The company claimed that it is the first evidence-based medicine to fight COVID-19.
Haridwar-based Patanjali Ayurved on Friday said Coronil has now received certification from Ayush Ministry as per World Health Organization (WHO) certification scheme.
The company claimed that it is the first evidence-based medicine to fight COVID-19.
The medicine was launched here at an event which was presided by Union Health Minister Harsh Vardhan and Transport Minister Nitin Gadkari.
“Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme,” said Patanjali in a statement.
Under CoPP, Coronil can now be exported to 158 countries.
Commenting of the development Swami Ramdev said, Coronil will help the humanity while providing affordable treatment based on naturopathy.
On the basis of presented data, the Ministry of Ayush has recognised Coronil Tablet as a medicine for “supporting measure in COVID-19.”
Patanjali had earlier introduced Ayurveda-based Coronil on June 23 last year, when the pandemic was at its peak.
However, it had to face severe criticism as it lacked scientific evidence.
Then, the Ayush Ministry had indicated it as “Immuno-booster” only.
Coronil is developed by Patanjali Research Institute. It had started work for an Ayurvedic remedy for COVID-19 in January, 2020.
We have taken all measures to ensure that the information provided in this article and on our social media platform is credible, verified and sourced from other Big media Houses. For any feedback or complaint, reach out to us at businessleaguein@gmail.com
